Aurobindo Pharma closing in on $5.5b Zentiva buyout

Largest Indian pharma M&A in final lap; PE firm GTCR only other contender. A portfolio company of Advent International, Zentiva will significantly boost Aurobindo’s European footprint.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Sa0FGJC
via IFTTT